ArticleBMJ open2024

Antireflux mucosal valvuloplasty versus proton pump inhibitors for the treatment of patients with gastro-oesophageal reflux disease in a tertiary healthcare centre in China: study protocol for a randomised controlled trial.

Xiaofen Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.